Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04704336 · ClinicalTrials.gov registry record · NA
Integration of Hypertension Management Into HIV Care in Nigeria
A NA study of Hypertension and Human Immunodeficiency Virus, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 830
- Enrollment target
- 2
- Study locations
NCT04704336: Active NA study of Hypertension and Human Immunodeficiency Virus, sponsored by NYU Langone Health.
NCT04704336 is a NA study of Hypertension and Human Immunodeficiency Virus that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 830 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04704336, a NA study of Hypertension and Human Immunodeficiency Virus, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 830 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates a tailored-practice facilitation (PF) strategy for integrating a task strengthening strategy for hypertension control (TASSH) for the care of patients living with HIV (PWH) within primary health centers (PHCs) in Lagos, Nigeria.
Primary Outcome
The primary outcome is change in systolic blood pressure (SBP) from baseline to 12 months. Following the research investigators' existing TASSH protocol, the SBP reduction in patients will assessed as mean change in systolic BP from baseline to 12 months. Blood pressure will be taken with valid automated BP device from the existing TASSH protocol.
Conditions Studied
Interventions
- BEHAVIORAL Task-shifting strategy for HTN control (TASSH) protocol
Study Locations (2)
Missouri
- Saint Louis University (SLU) - St Louis
Lagos
- Nigerian Institute of Medical Research (NIMR) - Yaba
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 830 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT04704336 still lists
NCT04704336 is an interventional study that assigns participants to a tested intervention. The registered 830 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Task-shifting strategy for HTN control (TASSH) protocol is the first listed.
NCT04704336 reports a single indexed study location in Missouri, Lagos.
Frequently Asked Questions
What is clinical trial NCT04704336 about?
NCT04704336 is a clinical study titled "Integration of Hypertension Management Into HIV Care in Nigeria". This study evaluates a tailored-practice facilitation (PF) strategy for integrating a task strengthening strategy for hypertension control (TASSH) for the care of patients living with HIV (PWH) within primary health centers (PHCs) in Lagos, Nigeria.
What is the current status of trial NCT04704336?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 830 participants. The study started on 2021-09-13. Estimated completion is 2026-01-31.
What conditions does trial NCT04704336 study?
This clinical trial studies the following conditions: Hypertension, Human Immunodeficiency Virus.
What interventions are being tested in trial NCT04704336?
The interventions under investigation include: Task-shifting strategy for HTN control (TASSH) protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT04704336?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04704336 being conducted?
This trial has 2 study locations across Missouri, Lagos. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04704336's enrollment target sits among peer trials
830 85th of 470 higher than 386 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- NCT06868277 · 830 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- NCT06910553 · 832 participants
IBD Pregnancy Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI